Nearly 1 in 3 older adults with certain ‘red flag’ conditions may have ATTR-CM
Nearly 1 in 3 older adults with heart issues or carpal tunnel may have undiagnosed ATTR-CM, a new study shows.
All articles by Clarissa Brincat
-
-
Gut bacteria may play a role in hereditary ATTR-CM
A recent study suggests that the gut microbiome might affect how hereditary transthyretin amyloid cardiomyopathy develops.
-
Amyloid deposits in the prostate could help diagnose ATTR-CM
Examining prostate tissue to check for amyloid deposits may help identify cases of transthyretin amyloid cardiomyopathy (ATTR-CM).
-
People with ATTR-CM breathe less efficiently during exercise, study finds
People with cardiac amyloidosis, particularly those with ATTR-CM, often breathe less efficiently during physical activity.
-
First patient treated in study aiming to prevent hereditary ATTR
ACT-EARLY is the first study to test whether early treatment can prevent the development of ATTR in people with a high-risk genetic variant.
-
Transthyretin-targeting therapies are effective for managing ATTR-CM
Drugs that target the transthyretin protein have life-extending potential for patients with ATTR-CM and are safe to use.
-
Case report shows amyloid can build up in the heart’s right atrium in ATTR-CM
A recent case report showed that transthyretin amyloid cardiomyopathy (ATTR-CM) may not always follow the same rules in every patient.
-
Patients with ATTR-CM are being diagnosed and treated earlier, but challenges remain
In the last decade, better awareness, improved diagnostic tools and new treatments have helped doctors diagnose ATTR-CM earlier on.
-
Research program aims to improve diagnosis of ATTR amyloidosis
A research initiative combining two studies aims to improve early diagnosis and treatment for patients with ATTR amyloidosis.
-
Diuretic dose can help monitor disease progression in ATTR-CM
A recent study found that needing a higher dose of diuretic can serve as a useful marker for tracking disease progression.
